Literature DB >> 24648910

Effects of black yeast-derived β-1,3-1,6-glucan on serum cytokine and microRNA expression in transplanted sarcoma in mice.

Wei Li1, Yaru Zhang2, Fengsong Cong2.   

Abstract

β-1,3-1,6-glucans are the most abundant glucose polymers in the cell walls of fungi. Previous studies have shown that β-1,3-1,6-glucans derived from fungi possess immunomodulating activitivies. Antitumor effects of these compounds have also been reported in animal models. Current studies mainly focus on the direct effects of β-1,3-1,6-glucans on immune systems, but no data are available to address the underlying molecular events in tumor cells. β-1,3-1,6-glucan purified from black yeast at 5 mg/100 g body weight (study group) or saline (control group) was intragastrically administered on a daily basis to subcutaneously-injected mice with mouse S180 sarcoma cells. Tumor sizes, tumor weights, serum concentrations of cytokines and levels of microRNAs (miRNAs) in transplanted tumors were compared between the treated and control groups. The volumes and weights of transplanted tumors were significantly lower in the treatment groups compared to the control groups by ∼150% and 70%, respectively. The treated mice demonstrated significantly higher levels of cytokines, including IL-2, IL-4, IL-6, IL-8, IL-10 and IL-12, compared to the control mice. Notably, the expression of several miRNAs in transplanted tumor tissues also markedly changed. These data suggest that black yeast-derived β-1,3-1,6-glucan, not only stimulates cytokine release from immune cells, but also changes the expression profiles of miRNAs in transplanted tumors.

Entities:  

Keywords:  S180 sarcoma cell; cytokine; microRNA; transplanted tumor; β-1,3-1,6-glucan

Year:  2012        PMID: 24648910      PMCID: PMC3956731          DOI: 10.3892/br.2012.30

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  27 in total

1.  Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast.

Authors:  Yoshuiyuki Kimura; Maho Sumiyoshi; Toshio Suzuki; Masahiro Sakanaka
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

2.  Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning.

Authors:  K Ariizumi; G L Shen; S Shikano; S Xu; R Ritter; T Kumamoto; D Edelbaum; A Morita; P R Bergstresser; A Takashima
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

3.  Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.

Authors:  Nai-Kong V Cheung; Shakeel Modak
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

4.  A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes.

Authors:  J W Zimmerman; J Lindermuth; P A Fish; G P Palace; T T Stevenson; D E DeMong
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

5.  Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.

Authors:  Dennis Löffler; Katja Brocke-Heidrich; Gabriele Pfeifer; Claudia Stocsits; Jörg Hackermüller; Antje K Kretzschmar; Renate Burger; Martin Gramatzki; Conny Blumert; Kay Bauer; Helena Cvijic; A Kerstin Ullmann; Peter F Stadler; Friedemann Horn
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

6.  Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.

Authors:  Matthias Brock; Michelle Trenkmann; Renate E Gay; Beat A Michel; Steffen Gay; Manuel Fischler; Silvia Ulrich; Rudolf Speich; Lars C Huber
Journal:  Circ Res       Date:  2009-04-23       Impact factor: 17.367

7.  Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill.

Authors:  M Mizuno; K Minato; H Ito; M Kawade; H Terai; H Tsuchida
Journal:  Biochem Mol Biol Int       Date:  1999-04

8.  Antitumour and immunological activity of a beta 1----3/1----6 glucan from Glomerella cingulata.

Authors:  K Gomaa; J Kraus; F Rosskopf; H Röper; G Franz
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Growth-inhibitory effects of a beta-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction.

Authors:  Mei Zhang; Lawrence C-M Chiu; Peter C K Cheung; Vincent E C Ooi
Journal:  Oncol Rep       Date:  2006-03       Impact factor: 3.906

Review 10.  The effects of beta-glucan on human immune and cancer cells.

Authors:  Godfrey Chi-Fung Chan; Wing Keung Chan; Daniel Man-Yuen Sze
Journal:  J Hematol Oncol       Date:  2009-06-10       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.